MedTrace Logo

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

NCT03249519 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 999

Last updated 2017-08-15

No results posted yet for this study

Summary

The combination of radiation therapy or chemoradiation with Interstitial brachytherapy for advanced cervical cancer (pN+, FIGO-Stage II B - IV A is standard of therapy. The radio- and chemosensitive effect of an additional hyperthermia might improve the clinical outcome.

Conditions

Interventions

RADIATION

Radiation

50.4 Gy

RADIATION

brachytherapy

35-40 Gy

DRUG

Cisplatin

weekly 40 mg/m\^2 (6cycles)

OTHER

Hyperthermia

10 times

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2094-12-31
Completion
2099-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249519 on ClinicalTrials.gov